The antibiotic blasticidin S (BlaS) is a potent inhibitor of protein synthesis in bacteria and eukaryotes. We have determined a 3.4-Å crystal structure of BlaS bound to a 70S·tRNA ribosome complex and performed biochemical and single-molecule FRET experiments to determine the mechanism of action of the antibiotic. We find that BlaS enhances tRNA binding to the P site of the large ribosomal subunit and slows down spontaneous intersubunit rotation in pretranslocation ribosomes. However, the antibiotic has negligible effect on elongation factor G catalyzed translocation of tRNA and mRNA. The crystal structure of the antibiotic-ribosome complex reveals that BlaS impedes protein synthesis through a unique mechanism by bending the 3′ terminus of the P-site tRNA toward the A site of the large ribosomal subunit. Biochemical experiments demonstrate that stabilization of the deformed conformation of the P-site tRNA by BlaS strongly inhibits peptidyl-tRNA hydrolysis by release factors and, to a lesser extent, peptide bond formation.peptidyl transfer | ribosome crystal structure | termination inhibitor | translation inhibitor | translation termination T he growing problem of pathogen resistance to existing antibacterials prompts a search for alternative modes of inhibiting bacterial growth. The development of new drugs can be facilitated by understanding the mechanisms of action of known antibiotics (1). Because of its central role in cell metabolism, the ribosome is the target of numerous inhibitors that bind to various sites on the ribosome and interfere with different steps of protein synthesis. One of the predominant modes of action of ribosomal antibiotics is the inhibition of peptide bond formation. A majority of peptidyltransferase inhibitors, including the widely used antibacterials chloramphenicol, linezolid, and the lincosamides lincomycin and clindamycin, bind to the A site of the large ribosomal subunit at the peptidyl-transferase center of the ribosome (2-4). By contrast, blasticidin S (BlaS) binds to the P site of the large subunit (5) and inhibits the peptidyl-transferase reaction through a distinct mechanism, which is still poorly understood.BlaS, produced by some Streptomyces species, is a nucleoside analog consisting of a cytosine bonded to a pyranose ring and attached to an N-methyl-guanidine tail (Fig. 1A). BlaS has long been known to be a potent inhibitor of protein synthesis in bacteria and eukaryotes (6, 7). A crystal structure of the 50S subunit from Haloarcula marismortui bound to BlaS in the absence of tRNA revealed that BlaS occupies the P site of the large subunit (5). Two molecules of BlaS interact with the P loop and form base pairs with the universally conserved G2251 and G2252 of 23S ribosomal RNA (Escherichia coli 70S ribosome numbering is used throughout this article). These base pairing interactions closely mimic those of the two cytosine residues of the conserved CCA 3′ terminus of tRNA bound in the P site. Based on the finding that two molecules of BlaS mimic the cytosine residues of the...